These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1157 related items for PubMed ID: 16621424

  • 1. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
    Benoit L, Anusca A, Ortega-Deballon P, Cheynel N, Bernard A, Favre JP.
    Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424
    [Abstract] [Full Text] [Related]

  • 2. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer.
    Prenzel KL, Mönig SP, Sinning JM, Baldus SE, Gutschow CA, Grass G, Schneider PM, Hölscher AH.
    J Surg Oncol; 2003 Apr; 82(4):256-60. PubMed ID: 12672010
    [Abstract] [Full Text] [Related]

  • 3. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
    Okada M, Sakamoto T, Yuki T, Mimura T, Nitanda H, Miyoshi K, Tsubota N.
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
    [Abstract] [Full Text] [Related]

  • 4. Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases.
    Casali C, Stefani A, Natali P, Rossi G, Morandi U.
    Eur J Cardiothorac Surg; 2005 Jul; 28(1):33-8. PubMed ID: 15953734
    [Abstract] [Full Text] [Related]

  • 5. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
    Riquet M, Assouad J, Bagan P, Foucault C, Le Pimpec Barthes F, Dujon A, Danel C.
    Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
    Sakao Y, Miyamoto H, Yamazaki A, Oh T, Fukai R, Shiomi K, Saito Y.
    Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
    [Abstract] [Full Text] [Related]

  • 8. Skip metastasis to the mediastinal lymph nodes in non-small cell lung cancer.
    Yoshino I, Yokoyama H, Yano T, Ueda T, Takai E, Mizutani K, Asoh H, Ichinose Y.
    Ann Thorac Surg; 1996 Oct; 62(4):1021-5. PubMed ID: 8823083
    [Abstract] [Full Text] [Related]

  • 9. Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer.
    Nakagiri T, Sawabata N, Funaki S, Inoue M, Kadota Y, Shintani Y, Okumura M.
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):733-8. PubMed ID: 21297135
    [Abstract] [Full Text] [Related]

  • 10. The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer.
    Misthos P, Sepsas E, Kokotsakis J, Skottis I, Lioulias A.
    Ann Thorac Surg; 2008 Nov; 86(5):1626-30. PubMed ID: 19049761
    [Abstract] [Full Text] [Related]

  • 11. [Skip metastasis to mediastinal lymph nodes: clinical significance and prognosis in stage III non-small cell lung cancer].
    Chen QK, Ding JA, Gao W, Zhu YM.
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jul; 28(7):472-4. PubMed ID: 16115397
    [Abstract] [Full Text] [Related]

  • 12. Vascular endothelial growth factor expression in pN2 non-small cell lung cancer: lack of prognostic value.
    Tomita M, Matsuzaki Y, Shimizu T, Hara M, Ayabe T, Onitsuka T.
    Respirology; 2005 Jan; 10(1):31-5. PubMed ID: 15691235
    [Abstract] [Full Text] [Related]

  • 13. Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2?
    Rea F, Marulli G, Callegaro D, Zuin A, Gobbi T, Loy M, Sartori F.
    Lung Cancer; 2004 Aug; 45(2):215-20. PubMed ID: 15246193
    [Abstract] [Full Text] [Related]

  • 14. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
    Decaluwé H, De Leyn P, Vansteenkiste J, Dooms C, Van Raemdonck D, Nafteux P, Coosemans W, Lerut T.
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
    [Abstract] [Full Text] [Related]

  • 15. Skip metastases: analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancer.
    Misthos P, Sepsas E, Athanassiadi K, Kakaris S, Skottis I.
    Eur J Cardiothorac Surg; 2004 Apr; 25(4):502-8. PubMed ID: 15037262
    [Abstract] [Full Text] [Related]

  • 16. [Skip metastasis to the mediastinal lymph nodes in non-small cell lung cancer].
    Wang S, Wu Y, Ou W.
    Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):259-61. PubMed ID: 11783103
    [Abstract] [Full Text] [Related]

  • 17. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
    Kang CH, Ra YJ, Kim YT, Jheon SH, Sung SW, Kim JH.
    Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
    [Abstract] [Full Text] [Related]

  • 18. Lobe-specific skip nodal metastasis in non-small cell lung cancer patients.
    Kawano R, Hata E, Ikeda S, Yokota T.
    Ann Thorac Cardiovasc Surg; 2008 Feb; 14(1):9-14. PubMed ID: 18292733
    [Abstract] [Full Text] [Related]

  • 19. Sentinel node sampling limits lymphadenectomy in stage I non-small cell lung cancer.
    Muraoka M, Akamine S, Oka T, Tagawa T, Nakamura A, Tsuchiya T, Hayashi T, Nagayasu T.
    Eur J Cardiothorac Surg; 2007 Aug; 32(2):356-61. PubMed ID: 17513118
    [Abstract] [Full Text] [Related]

  • 20. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
    Demir A, Turna A, Kocaturk C, Gunluoglu MZ, Aydogmus U, Urer N, Bedirhan MA, Gurses A, Dincer SI.
    Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.